info@neurochase.com

News & Articles

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

January 18, 2024 No Comments
Original Article: Global News Wire Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) — Spark [...]
Read more

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)

January 18, 2024 No Comments
Innervate Therapeutics is a biotechnology company focused on developing glial cell -derived neurotrophic factor (GDNF) gene therapies to achieve neuro-restoration and neuroprotection in diseases including PD and MND. GDNF, a [...]
Read more

Brain Tumor Therapy – A New Indication For Hamlet Pharma

January 18, 2024 No Comments
Original Article Today, Hamlet Pharma signed a joint development agreement with Neurochase Limited, founded by Professor Steven Gill, a world leading expert in the area of neurosurgery, to develop novel [...]
Read more

AviadoBio Announces Formation of Scientific Advisory Board

January 18, 2024 No Comments
AviadoBio, a pioneering, pre-clinical stage, gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, announces that it has established a Scientific Advisory Board (SAB) [...]
Read more
© 2024 Neurochase
Privacy Policy